Clinical trials: COVID19 Patients
COVID-19 Pneumonia
NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia
This is phase II study to assess the efficacy of NestaCell® (mesenchymal stem cell) to treat severe COVID-19 pneumonia.
- Trial name
- HOPE (NCT04315987)
- Testing
- NestaCell®
- Where
- 4 sites in Brazil
- Volunteers
- 90 people
- Sponsor
- Azidus Brasil
Covid19, Anosmia
Corticosteroid Nasal Spray in COVID-19 Anosmia
The aim of this study is to evaluate the role of the topical corticosteroids nasal spray (mometasone furoate nasal spray) in improving anosmia in patients recovered from COVID-19 infection.
- Trial name
- NCT04484493
- Testing
- mometasone furoate nasal spray
- Where
- Egypt
- Volunteers
- 100 people
- Sponsor
- Benha University
Cancer, COVID-19
Impact of the Coronavirus (COVID-19) on Patients With Cancer
The purpose of this study is to understand the impact of COVID-19 on patients with cancer through a survey.
- Trial name
- NCT04330521
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- Stanford University
Corona Virus Infection, COVID-19
Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia
In-vitro studies revealed that nafamostat mesylate has antiviral activity against Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and anti-inflammatory and anti-coagulation effect.
- Trial name
- NCT04418128
- Testing
- Nafamostat Mesylate
- Volunteers
- 84 people
- Sponsor
- Gyeongsang National University Hospital
COVID-19 Respiratory Infection, Parkinson Disease
Chest Mobility, Strength, Physical Activity and Quality of Life in Parkinson's Patients With Post-COVID-19
To comparative pain intensity, chest mobility, cough strength, muscle strength, physical activity levels and quality of life in Parkinson's patients with post-COVID-19 and without post-COVID-19 was aimed in current study.
- Trial name
- NCT06008444
- Testing
- Physical Evaluations of post-COVID-19 individuals, Physical Evaluations of non-post-COVID-19 individuals
- Where
- Turkey (Türkiye)
- Volunteers
- 32 people
- Sponsor
- Izmir Democracy University
Covid19, Severe Mental Disorder
COVID-19 Serological Testing of Patients With a Mental Disorder From the Catchment Area of the Capital Region of Denmark
The pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has lately caused worldwide health problems.
- Trial name
- NCT04775407
- Testing
- blood sampling
- Where
- Denmark
- Volunteers
- 1,355 people
- Sponsor
- Anders Fink-Jensen, MD, DMSci
COVID
To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study)
This is an observational study for Corona virus disease by the Max Healthcare.Corona virus 2019 disease (COVID-19) is a respiratory tract infectious disease caused by a newly emergent corona virus.
- Trial name
- SCOPe (NCT04367064)
- Where
- India
- Volunteers
- 1,000 people
- Sponsor
- Max Healthcare Insititute Limited
Post COVID-19 Condition, Post COVID-19 Condition (PCC)
Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients
This randomized controlled study evaluates the effects of cold water hydrotherapy in patients with Post-COVID Syndrome. The primary aim is to assess changes in quality of life compared to an usual care setting without…
- Conditions
- Post COVID-19 Condition, Post COVID-19 Condition (PCC), Post COVID-19, Post COVID-19 Syndrome
- Trial name
- HydroCoVitalB (NCT07110714)
- Testing
- Cold water hydrotherapy
- Where
- Germany
- Volunteers
- 30 people
- Sponsor
- Eggensberger OHG
Covid19, Pneumonia
Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia
The novel coronavirus SARS-CoV-2 (COVID-19) is an emerging respiratory virus that causes pneumonia. WHO data reported admission to the intensive care unit (ICU) for 6% of patients, with a mortality rate reaching 45%.
- Trial name
- MultiCov (NCT04334850)
- Testing
- Combined use of a respiratory broad panel multiplex PCR and procalcitonin, Usual antibiotic treatment
- Where
- France
- Volunteers
- 194 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Covid19
A Simple Approach to Prevent Hospitalization for COVID-19 Patients
The newly recognised disease COVID-19 is caused by the Severe-Acute-Respiratory-Syndrome Coronavirus 2 (SARS-CoV-2), which rapidly spread globally in late 2019, reaching pandemic proportions.
- Trial name
- COVER2 (NCT04854824)
- Testing
- Recommended treatment schedule, Control treatment schedule
- Where
- 2 sites in Italy
- Volunteers
- 216 people
- Sponsor
- Mario Negri Institute for Pharmacological Research
Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus
To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients
This is a randomized, randomized controlled trial to investigate the efficacy and safety of Neurokinin-1 Receptor (NK-1R) 80 mg orally given daily to treat cytokine storm causing inflammatory lung injury and respiratory failure…
- Trial name
- NCT04468646
- Testing
- NK-1R antagonist
- Where
- Pakistan
- Volunteers
- 100 people
- Sponsor
- Prof. Dr. Fridoon Jawad Ahmad
Mechanical Ventilation, SARS-CoV-2
Transpulmonary Driving Pressure in ARDS COVID19 Patients
A majority (65-85%) of critically ill patients admitted in intensive care units with a confirmed diagnostic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) developed an acute respiratory distress syndrome (ARDS)…
- Conditions
- Mechanical Ventilation, SARS-CoV-2, COVID-19
- Trial name
- TRANSPULMONARY (NCT04381286)
- Where
- France
- Volunteers
- 40 people
- Sponsor
- University Hospital, Montpellier
Covid19
Relaxation Exercise in Patients With COVID-19
the aim of this study is to investigate the effect of relaxation techniques on immune biomarkers and disease severity and progression in patients with COVID-19 and the period to which these changes last.
- Trial name
- NCT04998708
- Testing
- Relaxation technique
- Where
- Turkey (Türkiye)
- Volunteers
- 30 people
- Sponsor
- Beni-Suef University
COVID-19 Acute Respiratory Distress Syndrome
Is Prolonged Period of Prone Position Effective and Safe in Mechanically Ventilated Patients With SARS-COV-2?
the aim of the study is to assess safety and efficacy of prone position ventilation beyond the usual 16 hrs in patients with SARS-COV-2
- Trial name
- NCT05109624
- Testing
- prolonged prone position ventilation
- Where
- Egypt
- Volunteers
- 52 people
- Sponsor
- Ain Shams University
COVID-19, Critical Illness
Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19
Objective of this observational multicentric retrospective-prospective study is to describe the number and the characteristics of patients with Reverse Transcription Polymerase Chain Reaction (RT-PCR) for SARS-CoV2 positivity…
- Trial name
- 2019nCoV_ICU (NCT04388670)
- Where
- Italy
- Volunteers
- 1,500 people
- Sponsor
- Policlinico Hospital
SARS-CoV Infection, Seroprevalence
Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study
The investigator analyzed the data of the patients admitted to the surgical department during the period 1St September - 10Th December 2020 to estimate the seroprevalence of SARS-CoV-2 infection in the setting of a non-dedicated…
- Conditions
- SARS-CoV Infection, Seroprevalence, Covid19
- Trial name
- COVID-19 (NCT04839913)
- Testing
- Antibodies testing
- Where
- Italy
- Volunteers
- 121 people
- Sponsor
- University of Cagliari
Covid19
Management of Patients Suspected of COVID 19 With Ultra Low Dose Thoracic Scanner
The year 2020 was marked by the emergence of a new respiratory disease: COVID19 related to an infection with the coronavirus SARS-CoV-2 (name given by the WHO on February 11, 2020).
- Trial name
- COVID-19 ULD (NCT04794361)
- Where
- France
- Volunteers
- 400 people
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
COVID-19
Exploring the Experiences, Expectations and Preferences of Patients With the UHS COVID-19 Follow-up Clinic
People who are older, those who had underlying other health conditions and people living in poorer communities are at increased risk of complications and worse outcome from COVID-19.
- Trial name
- NCT05799482
- Testing
- Qualitative Interview
- Where
- United Kingdom
- Volunteers
- 30 people
- Sponsor
- University Hospital Southampton NHS Foundation Trust
Coronavirus
Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection
Outbreak of 2019 Novel Coronavirus infection started in Wuhan and quickly spread to the world. Suspected patients were isolated and treated in our department.
- Trial name
- NCT04279782
- Testing
- Comprehensive treatment
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Third Affiliated Hospital, Sun Yat-Sen University
COVID-19, Lung Function Decreased
Pulmonary Function and CT Scan Finding in CKD Patients After COVID-19 Infection
COVID-19 is associated with increased morbidity and mortality in patients with chronic kidney disease (CKD) on dialysis. CKD requires particular emphasis during the pandemic due to concern for increased susceptibility to…
- Conditions
- COVID-19, Lung Function Decreased, Xray Complication
- Trial name
- NCT05348759
- Testing
- Pulmonary function test, Chest computer scan
- Where
- Thailand
- Volunteers
- 100 people
- Sponsor
- Bangkok Metropolitan Administration Medical College and Vajira Hospital
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.